title: Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?
authors.forename: Deven
authors.initials: D
authors.lastname: Patel
authors.forename: Claire
authors.initials: C
authors.lastname: Thorne
authors.forename: Simona
authors.initials: S
authors.lastname: Fiore
authors.forename: Marie-Louise
authors.initials: ML
authors.lastname: Newell
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D005060:Europe / Q000453:epidemiology; D005260:Female; D005865:Gestational Age; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000209:etiology; D011256:Pregnancy Outcome / Q000453:epidemiology*; D015995:Prevalence; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents